Press Release Ipsen delivers excellent H1 2026 results and upgrades its full-year guidance 11 hours ago
Press Release Ipsen nominates Catherine Bradley to its Board of Directors as independent Director Jul 29
Press Release Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen’s Rare Disease pipeline Jul 22